Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H24N2O2 |
Molecular Weight | 312.4061 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(C1CCCCC1)N2CC3N(CCC4=C3C=CC=C4)C(=O)C2
InChI
InChIKey=FSVJFNAIGNNGKK-UHFFFAOYSA-N
InChI=1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2
Molecular Formula | C19H24N2O2 |
Molecular Weight | 312.4061 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:02:30 UTC 2023
by
admin
on
Fri Dec 15 18:02:30 UTC 2023
|
Record UNII |
6490C9U457
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA VETERINARY ASSESSMENT REPORTS |
PROFENDER [AUTHORIZED]
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.1872
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.1870
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.1.3
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
BROADLINE(AUTHORIZED)
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.1200
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.1871
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 522.1870
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
WHO-VATC |
QP52AA01
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.1199
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
WHO-VATC |
QP52AA51
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
LIVERTOX |
NBK548916
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.903D
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.1453
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.1.1
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.1445
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
NDF-RT |
N0000175481
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
EMA VETERINARY ASSESSMENT REPORTS |
PROFENDER [AUTHORIZED]
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.1447
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
WHO-ATC |
P02BA01
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 520.1198
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
FDA ORPHAN DRUG |
19487
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
||
|
CFR |
21 CFR 524.775
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
757285
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
D011223
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
1554603
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
100000081420
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
CHEMBL976
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
Praziquantel
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
259-559-6
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
SUB10008MIG
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
DB01058
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
4891
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
55268-74-1
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
PRAZIQUANTEL
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
6490C9U457
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
PRAZIQUANTEL
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder; odourless or with a faint characteristic odour. Solubility: Very slightly soluble in water; freely soluble in ethanol (~750 g/l) TS. Category: Antischistosomal drug. Storage: Praziquantel should be kept in a well-closed container, protected from light. Definition: Praziquantel contains not less than 98.5% and not more than 101.0% of C19H24N2O2, calculated with reference to thedried substance. | ||
|
m9107
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | Merck Index | ||
|
2241
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
6490C9U457
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
8628
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | RxNorm | ||
|
3895
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
C47683
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY | |||
|
DTXSID9021182
Created by
admin on Fri Dec 15 18:02:30 UTC 2023 , Edited by admin on Fri Dec 15 18:02:30 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
TARGET ORGANISM->INHIBITOR |
|
||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||